Icosavax, Inc. announced it raised $99.7 Million in an initial filing from an offering of $99.7 Million

Apr 07, 2021•over 4 years ago

Amount Raised

$99.7 Million

SeattleBiotechnology

Company Information

Company

Icosavax, Inc.

Location

1616 Eastlake Ave. E, Ste. 208

Seattle, Washington, United States

About

Computationally Designed VLP Vaccines Computationally designed proteins that self-assemble into virus-like particles (VLPs), we are able to readily manufacture VLPs displaying complex antigens to target significant unmet medical needs. Protect from respiratory syncytial virus (RSV) disease.

Related People

Funding Insights

Based on industry data

Tech investment trends

83% of B2B companies plan digital investments, with 79% prioritizing customer experience tech